21 Mar 2023

Global Biopharmaceutical Company Moves Into Westworks

invoX Pharma Ltd (invoX), a global biopharmaceutical company, has agreed to set up its UK headquarters in the WestWorks building at White City Place.

invoX’s mission is to be a fully integrated biopharmaceutical company with an advancing pipeline of innovative products addressing unmet healthcare needs, worldwide. At its core, the company aspires to improve patients’ lives by creating access to innovative medicine.

invoX is well on its way, through multiple acquisitions and investments, to create a scalable platform to build a portfolio of promising clinical and pre-clinical stage drug candidates. invoX recently completed the acquisition of F-star therapeutics, a clinical-stage biopharmaceutical company pioneering bispecific antibodies in immunotherapy. These programs have the potential to improve people’s lives by creating access to innovative medicine across some key therapeutic areas including oncology and respiratory.

invoX Pharma Ltd is a wholly-owned subsidiary of Sino Biopharmaceutical Limited, a global top 50 pharmaceutical company with more than 24,000 employees. invoX's international centre of excellence in antibody research and clinical development is based in Cambridge which is a part of the Golden Triangle with Oxford and London universities.